ReviewCancers2021

Potential Biomarkers for Treatment Response to the BCL-2 Inhibitor Venetoclax: State of the Art and Future Directions.

Haneen T Salah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.